Literature DB >> 8486964

Geographic variation in the humoral response to Pneumocystis carinii.

A G Smulian1, D W Sullivan, M J Linke, N A Halsey, T C Quinn, A P MacPhail, M A Hernandez-Avila, S T Hong, P D Walzer.   

Abstract

The reported incidence of Pneumocystis carinii pneumonia varies in different areas of the world, but little is known about geographic variation in the antibody response to specific antigens. The frequency of anti-P. carinii antibodies in the serum of normal and human immunodeficiency virus (HIV)-infected individuals from five different regions was compared. Serum specimens from 948 subjects were assayed for IgG antibodies to human-derived P. carinii by Western blot. The overall prevalence of anti-P. carinii antibodies was 72.9%. Among HIV-seronegative individuals, the rate of seropositivity was similar in all regions (70.5%-82.4%). Antibodies to the 30- to 40-kDa antigen were most commonly detected. The frequency of antibodies to high-molecular-mass antigens (95, 120, and > 120 kDa) demonstrated significant geographic variation. This study demonstrates that antibody responses to P. carinii are common in all areas studied but vary in frequency and pattern.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486964     DOI: 10.1093/infdis/167.5.1243

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Regional Differences in the Prevalence of Major Opportunistic Infections among Antiretroviral-Naïve Human Immunodeficiency Virus Patients in Japan, Northern Thailand, Northern Vietnam, and the Philippines.

Authors:  Louie Mar A Gangcuangco; Ikumi Sawada; Naho Tsuchiya; Cuong D Do; Thanh Thuy T Pham; Archawin Rojanawiwat; Marissa Alejandria; Katerina Leyritana; Yoshiyuki Yokomaku; Panita Pathipvanich; Koya Ariyoshi
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones.

Authors:  K R Daly; J V Koch; N J Shire; L Levin; P D Walzer
Journal:  Clin Vaccine Immunol       Date:  2006-10

Review 4.  Pneumocystis carinii: what is it, exactly?

Authors:  J R Stringer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 5.  Tropical respiratory medicine. 1. Pulmonary infections in the tropics: impact of HIV infection.

Authors:  C L Daley
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

Review 6.  AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

Review 7.  Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients.

Authors:  Adem Ilkay Diken; Ozlem Erçen Diken; Onur Hanedan; Seyhan Yılmaz; Ata Niyazi Ecevit; Emir Erol; Adnan Yalçınkaya
Journal:  World J Transplant       Date:  2016-03-24

8.  Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region.

Authors:  Q Mei; R E Turner; V Sorial; D Klivington; C W Angus; J A Kovacs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

Authors:  S A Theus; D W Sullivan; P D Walzer; A G Smulian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii.

Authors:  M J Linke; A G Smulian; J R Stringer; P D Walzer
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.